VNDA Competitors & Alternatives
Compare Vanda Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
VNDA
Main Stock$3.80
-4.89%
Tradestie Score
48
Market Cap
$301.35M
Revenue Growth
24.1%
Analyst Upside
+203.0%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 1/10
Drug Discovery Biotech
Drug Design
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DBVT
DBV Technologies S.A.
|
$10.26
-6.85%
|
$275.54M | - | 30 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$19.26
-0.82%
|
$269.08M | 0.1 | 58 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
+0.14%
|
$256.71M | - | 51 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.82
-0.08%
|
$240.89M | - | 44 | Compare |
|
IRWD
Ironwood Pharmaceuticals, Inc. - Class A
|
$4.85
+0.31%
|
$237.15M | 5.4 | 35 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.92
+0.10%
|
$231.77M | - | 42 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$10.29
+0.68%
|
$227.00M | - | 42 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.40
-5.92%
|
$211.22M | - | 60 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.65
-7.02%
|
$202.58M | - | 36 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$13.20
-6.71%
|
$199.71M | - | 37 | Compare |
More VNDA Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry